IBAB Ion Beam Applications SA

IBA – Transparency Notification

IBA – Transparency Notification

 

IBA – TRANSPARENCY NOTIFICATION

(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)

Louvain-la-Neuve, Belgium, February 11th, 2025 06:00

Summary of the notification

IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on February 6, 2025.

In its notification, IBA SA indicated that following a transfer of securities or voting rights. Its total shareholding in IBA SA decreased and its shareholding in IBA shares with voting rights fell below the 2% threshold on 06/02/2025.

Content of the notification

  • Reason for the notification: Acquisition or disposal of securities or voting rights
  • Notification by: A parent company or controlling person
  • Persons subject to the notification requirement:
  • Date on which the threshold is crossed: 06/02/2025
  • Threshold crossed (in %) : 2%
  • Denominator : 40.514.366
  • Notified details: (extract of the received notification form)

Complete chain of controlled companies through which the holding is effectively held.

IBA Investments SRL is a 100% owned subsidiary of Ion Beam Applications SA.

IBA SA is not a controlled entity.

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2.000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at:

For further information, please contact:

Valérie Van Impe

Paralegal



Attachment



EN
11/02/2025

Underlying

IBABIon Beam Applications SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

 PRESS RELEASE
Free
IBAB Ion Beam Applic...

Notice of Capital Markets Day - Save the Date

Notice of Capital Markets Day - Save the Date Louvain-la-Neuve, Belgium, 18 February, 2025 –  (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will host a Capital Markets Day (CMD) for investors and analysts on Monday 7 April 2025 at 2pm CET / 1pm GMT / 8am ET. The event will include presentations, panel discussions and Q&A sessions led by IBA’s management team with speakers from across the Group. Attendees will have the opportunity to gain valuable insights into IBA’s strategy, including selected growth initiatives and performance drivers, as w...

February 18, 2025 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – Transparency Notification IBA SA

IBA – Transparency Notification IBA SA   IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, February 11th, 2025 06:00 Summary of the notification IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on February 6,...

February 11, 2025 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – Transparency Notification

IBA – Transparency Notification   IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, February 11th, 2025 06:00 Summary of the notification IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on February 6, 2025. In its no...

February 11, 2025 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA - PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE

IBA - PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE   IBA SA – NOTIFICATION TRANSPARENCE (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 11 février 2025, 18h Résumé de la notification IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce devoir effectuer une notification en matière de transparence conformément à l'article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations impor...

February 11, 2025 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – Transparency Notification

IBA – Transparency Notification   IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, February 11th, 2025 06:00 Summary of the notification IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on February 6, 2025. In its no...

February 11, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch